APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioartificial Organ Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bioartificial Organ Manufacturing Market Outlook and Growth Opportunities 2026

16 January 2026207 pages

Choose your research edition.

Industry ResearchBioartificial Organ Manufacturing Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioartificial Organ Manufacturing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Bioartificial Organ Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioartificial Organ Manufacturing Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioartificial Organ Manufacturing Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Bioartificial Organ Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bioartificial Organ Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioartificial Organ Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioartificial Organ Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bioartificial Organ Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bioartificial Organ Manufacturing market include B. Braun, Boston Scientific Corporation, ABIOMED, Asahi Kasei Corporation, Berlin Heart, CARMAT, Jarvik Heart, SynCardia Systems and Nipro Europe Group Companies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bioartificial Organ Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioartificial Organ Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioartificial Organ Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bioartificial Organ Manufacturing market.

Bioartificial Organ Manufacturing Segment by Company

B. Braun

Boston Scientific Corporation

ABIOMED

Asahi Kasei Corporation

Berlin Heart

CARMAT

Jarvik Heart

SynCardia Systems

Nipro Europe Group Companies

Organovo Holdings

NexImmune

Diabeloop

Admetsys

Defymed

Pancreum

Beta Bionics

Integra LifeSciences

Wake Forest Institute for Regenerative Medicine (WFIRM)

Bioartificial Organ Manufacturing Segment by Type

Semi-automatic

Fully Automatic

Manual

Bioartificial Organ Manufacturing Segment by Application

Hospitals

Research Institutes

Laboratory

Others

Bioartificial Organ Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bioartificial Organ Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bioartificial Organ Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Bioartificial Organ Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bioartificial Organ Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bioartificial Organ Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Bioartificial Organ Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioartificial Organ Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioartificial Organ Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioartificial Organ Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bioartificial Organ Manufacturing industry.

Chapter 3: Detailed analysis of Bioartificial Organ Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bioartificial Organ Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bioartificial Organ Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bioartificial Organ Manufacturing Industry Trends Table 2. Bioartificial Organ Manufacturing Industry Drivers Table 3. Bioartificial Organ Manufacturing Industry Opportunities and Challenges Table 4. Bioartificial Organ Manufacturing Industry Restraints Table 5. Global Bioartificial Organ Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bioartificial Organ Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Bioartificial Organ Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bioartificial Organ Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Bioartificial Organ Manufacturing Company, Product Type & Application Table 10. Global Bioartificial Organ Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bioartificial Organ Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Semi-automatic Table 15. Significant Companies of Fully Automatic Table 16. Significant Companies of Manual Table 17. Global Bioartificial Organ Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Bioartificial Organ Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Bioartificial Organ Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Bioartificial Organ Manufacturing Sales Value Share by Type (2021-2026) Table 21. Global Bioartificial Organ Manufacturing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Research Institutes Table 24. Significant Companies of Laboratory Table 25. Significant Companies of Others Table 26. Global Bioartificial Organ Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Bioartificial Organ Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Bioartificial Organ Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Bioartificial Organ Manufacturing Sales Value Share by Application (2021-2026) Table 30. Global Bioartificial Organ Manufacturing Sales Value Share by Application (2027-2032) Table 31. Global Bioartificial Organ Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Bioartificial Organ Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Bioartificial Organ Manufacturing Sales Value Share by Region (2021-2026) Table 34. Global Bioartificial Organ Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Bioartificial Organ Manufacturing Sales Value Share by Region (2027-2032) Table 36. Global Bioartificial Organ Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Bioartificial Organ Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Bioartificial Organ Manufacturing Sales Value Market Share by Country (2021-2026) Table 39. Global Bioartificial Organ Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Bioartificial Organ Manufacturing Sales Value Market Share by Country (2027-2032) Table 41. B. Braun Company Information Table 42. B. Braun Business Overview Table 43. B. Braun Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. B. Braun Bioartificial Organ Manufacturing Product Portfolio Table 45. B. Braun Recent Development Table 46. Boston Scientific Corporation Company Information Table 47. Boston Scientific Corporation Business Overview Table 48. Boston Scientific Corporation Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Boston Scientific Corporation Bioartificial Organ Manufacturing Product Portfolio Table 50. Boston Scientific Corporation Recent Development Table 51. ABIOMED Company Information Table 52. ABIOMED Business Overview Table 53. ABIOMED Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. ABIOMED Bioartificial Organ Manufacturing Product Portfolio Table 55. ABIOMED Recent Development Table 56. Asahi Kasei Corporation Company Information Table 57. Asahi Kasei Corporation Business Overview Table 58. Asahi Kasei Corporation Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Asahi Kasei Corporation Bioartificial Organ Manufacturing Product Portfolio Table 60. Asahi Kasei Corporation Recent Development Table 61. Berlin Heart Company Information Table 62. Berlin Heart Business Overview Table 63. Berlin Heart Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Berlin Heart Bioartificial Organ Manufacturing Product Portfolio Table 65. Berlin Heart Recent Development Table 66. CARMAT Company Information Table 67. CARMAT Business Overview Table 68. CARMAT Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. CARMAT Bioartificial Organ Manufacturing Product Portfolio Table 70. CARMAT Recent Development Table 71. Jarvik Heart Company Information Table 72. Jarvik Heart Business Overview Table 73. Jarvik Heart Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Jarvik Heart Bioartificial Organ Manufacturing Product Portfolio Table 75. Jarvik Heart Recent Development Table 76. SynCardia Systems Company Information Table 77. SynCardia Systems Business Overview Table 78. SynCardia Systems Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. SynCardia Systems Bioartificial Organ Manufacturing Product Portfolio Table 80. SynCardia Systems Recent Development Table 81. Nipro Europe Group Companies Company Information Table 82. Nipro Europe Group Companies Business Overview Table 83. Nipro Europe Group Companies Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Nipro Europe Group Companies Bioartificial Organ Manufacturing Product Portfolio Table 85. Nipro Europe Group Companies Recent Development Table 86. Organovo Holdings Company Information Table 87. Organovo Holdings Business Overview Table 88. Organovo Holdings Bioartificial Organ Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Organovo Holdings Bioartificial Organ Manufacturing Product Portfolio Table 90. Organovo Holdings Recent Development Table 91. NexImmune Company Information Table 92. NexImmune Business Overview Table 93. NexImmune Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. NexImmune Bioartificial Organ Manufacturing Product Portfolio Table 95. NexImmune Recent Development Table 96. Diabeloop Company Information Table 97. Diabeloop Business Overview Table 98. Diabeloop Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Diabeloop Bioartificial Organ Manufacturing Product Portfolio Table 100. Diabeloop Recent Development Table 101. Admetsys Company Information Table 102. Admetsys Business Overview Table 103. Admetsys Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Admetsys Bioartificial Organ Manufacturing Product Portfolio Table 105. Admetsys Recent Development Table 106. Defymed Company Information Table 107. Defymed Business Overview Table 108. Defymed Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Defymed Bioartificial Organ Manufacturing Product Portfolio Table 110. Defymed Recent Development Table 111. Pancreum Company Information Table 112. Pancreum Business Overview Table 113. Pancreum Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Pancreum Bioartificial Organ Manufacturing Product Portfolio Table 115. Pancreum Recent Development Table 116. Beta Bionics Company Information Table 117. Beta Bionics Business Overview Table 118. Beta Bionics Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Beta Bionics Bioartificial Organ Manufacturing Product Portfolio Table 120. Beta Bionics Recent Development Table 121. Integra LifeSciences Company Information Table 122. Integra LifeSciences Business Overview Table 123. Integra LifeSciences Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Integra LifeSciences Bioartificial Organ Manufacturing Product Portfolio Table 125. Integra LifeSciences Recent Development Table 126. Wake Forest Institute for Regenerative Medicine (WFIRM) Company Information Table 127. Wake Forest Institute for Regenerative Medicine (WFIRM) Business Overview Table 128. Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Product Portfolio Table 130. Wake Forest Institute for Regenerative Medicine (WFIRM) Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Bioartificial Organ Manufacturing Product Image Figure 2. Global Bioartificial Organ Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioartificial Organ Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioartificial Organ Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Semi-automatic Image Figure 8. Fully Automatic Image Figure 9. Manual Image Figure 10. Global Bioartificial Organ Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Bioartificial Organ Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Bioartificial Organ Manufacturing Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Research Institutes Image Figure 15. Laboratory Image Figure 16. Others Image Figure 17. Global Bioartificial Organ Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Bioartificial Organ Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Bioartificial Organ Manufacturing Sales Value Share by Application (2021-2032) Figure 20. Global Bioartificial Organ Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Bioartificial Organ Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Bioartificial Organ Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Bioartificial Organ Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Bioartificial Organ Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Bioartificial Organ Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Bioartificial Organ Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Bioartificial Organ Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Bioartificial Organ Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Bioartificial Organ Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Bioartificial Organ Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Bioartificial Organ Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Semi-automatic
  • Fully Automatic
  • Manual
Applications
  • Hospitals
  • Research Institutes
  • Laboratory
  • Others
Companies covered
  • B. Braun
  • Boston Scientific Corporation
  • ABIOMED
  • Asahi Kasei Corporation
  • Berlin Heart
  • CARMAT
  • Jarvik Heart
  • SynCardia Systems
  • Nipro Europe Group Companies
  • Organovo Holdings
  • NexImmune
  • Diabeloop
  • Admetsys
  • Defymed
  • Pancreum
  • Beta Bionics
  • Integra LifeSciences
  • Wake Forest Institute for Regenerative Medicine (WFIRM)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioartificial Organ Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioartificial Organ Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bioartificial Organ Manufacturing Market Dynamics
  1. 2.1 Bioartificial Organ Manufacturing Industry Trends
  2. 2.2 Bioartificial Organ Manufacturing Industry Drivers
  3. 2.3 Bioartificial Organ Manufacturing Industry Opportunities and Challenges
  4. 2.4 Bioartificial Organ Manufacturing Industry Restraints
3 Bioartificial Organ Manufacturing Market by Company
  1. 3.1 Global Bioartificial Organ Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Bioartificial Organ Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Bioartificial Organ Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Bioartificial Organ Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Bioartificial Organ Manufacturing Company Product Type and Application
  6. 3.6 Global Bioartificial Organ Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bioartificial Organ Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bioartificial Organ Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bioartificial Organ Manufacturing Market by Type
  1. 4.1 Bioartificial Organ Manufacturing Type Introduction
  2. 4.1.1 Semi-automatic
  3. 4.1.2 Fully Automatic
  4. 4.1.3 Manual
  5. 4.2 Global Bioartificial Organ Manufacturing Sales Value by Type
  6. 4.2.1 Global Bioartificial Organ Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bioartificial Organ Manufacturing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Bioartificial Organ Manufacturing Sales Value Share by Type (2021-2032)
5 Bioartificial Organ Manufacturing Market by Application
  1. 5.1 Bioartificial Organ Manufacturing Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Research Institutes
  4. 5.1.3 Laboratory
  5. 5.1.4 Others
  6. 5.2 Global Bioartificial Organ Manufacturing Sales Value by Application
  7. 5.2.1 Global Bioartificial Organ Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bioartificial Organ Manufacturing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Bioartificial Organ Manufacturing Sales Value Share by Application (2021-2032)
6 Bioartificial Organ Manufacturing Regional Value Analysis
  1. 6.1 Global Bioartificial Organ Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioartificial Organ Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bioartificial Organ Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bioartificial Organ Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioartificial Organ Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Bioartificial Organ Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bioartificial Organ Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Bioartificial Organ Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bioartificial Organ Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bioartificial Organ Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bioartificial Organ Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Bioartificial Organ Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bioartificial Organ Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bioartificial Organ Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Bioartificial Organ Manufacturing Country-level Value Analysis
  1. 7.1 Global Bioartificial Organ Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bioartificial Organ Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bioartificial Organ Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bioartificial Organ Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bioartificial Organ Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bioartificial Organ Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bioartificial Organ Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 B. Braun
  2. 8.1.1 B. Braun Company Information
  3. 8.1.2 B. Braun Business Overview
  4. 8.1.3 B. Braun Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 B. Braun Bioartificial Organ Manufacturing Product Portfolio
  6. 8.1.5 B. Braun Recent Developments
  7. 8.2 Boston Scientific Corporation
  8. 8.2.1 Boston Scientific Corporation Company Information
  9. 8.2.2 Boston Scientific Corporation Business Overview
  10. 8.2.3 Boston Scientific Corporation Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Corporation Bioartificial Organ Manufacturing Product Portfolio
  12. 8.2.5 Boston Scientific Corporation Recent Developments
  13. 8.3 ABIOMED
  14. 8.3.1 ABIOMED Company Information
  15. 8.3.2 ABIOMED Business Overview
  16. 8.3.3 ABIOMED Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ABIOMED Bioartificial Organ Manufacturing Product Portfolio
  18. 8.3.5 ABIOMED Recent Developments
  19. 8.4 Asahi Kasei Corporation
  20. 8.4.1 Asahi Kasei Corporation Company Information
  21. 8.4.2 Asahi Kasei Corporation Business Overview
  22. 8.4.3 Asahi Kasei Corporation Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Asahi Kasei Corporation Bioartificial Organ Manufacturing Product Portfolio
  24. 8.4.5 Asahi Kasei Corporation Recent Developments
  25. 8.5 Berlin Heart
  26. 8.5.1 Berlin Heart Company Information
  27. 8.5.2 Berlin Heart Business Overview
  28. 8.5.3 Berlin Heart Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Berlin Heart Bioartificial Organ Manufacturing Product Portfolio
  30. 8.5.5 Berlin Heart Recent Developments
  31. 8.6 CARMAT
  32. 8.6.1 CARMAT Company Information
  33. 8.6.2 CARMAT Business Overview
  34. 8.6.3 CARMAT Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CARMAT Bioartificial Organ Manufacturing Product Portfolio
  36. 8.6.5 CARMAT Recent Developments
  37. 8.7 Jarvik Heart
  38. 8.7.1 Jarvik Heart Company Information
  39. 8.7.2 Jarvik Heart Business Overview
  40. 8.7.3 Jarvik Heart Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jarvik Heart Bioartificial Organ Manufacturing Product Portfolio
  42. 8.7.5 Jarvik Heart Recent Developments
  43. 8.8 SynCardia Systems
  44. 8.8.1 SynCardia Systems Company Information
  45. 8.8.2 SynCardia Systems Business Overview
  46. 8.8.3 SynCardia Systems Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SynCardia Systems Bioartificial Organ Manufacturing Product Portfolio
  48. 8.8.5 SynCardia Systems Recent Developments
  49. 8.9 Nipro Europe Group Companies
  50. 8.9.1 Nipro Europe Group Companies Company Information
  51. 8.9.2 Nipro Europe Group Companies Business Overview
  52. 8.9.3 Nipro Europe Group Companies Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nipro Europe Group Companies Bioartificial Organ Manufacturing Product Portfolio
  54. 8.9.5 Nipro Europe Group Companies Recent Developments
  55. 8.10 Organovo Holdings
  56. 8.10.1 Organovo Holdings Company Information
  57. 8.10.2 Organovo Holdings Business Overview
  58. 8.10.3 Organovo Holdings Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Organovo Holdings Bioartificial Organ Manufacturing Product Portfolio
  60. 8.10.5 Organovo Holdings Recent Developments
  61. 8.11 NexImmune
  62. 8.11.1 NexImmune Company Information
  63. 8.11.2 NexImmune Business Overview
  64. 8.11.3 NexImmune Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NexImmune Bioartificial Organ Manufacturing Product Portfolio
  66. 8.11.5 NexImmune Recent Developments
  67. 8.12 Diabeloop
  68. 8.12.1 Diabeloop Company Information
  69. 8.12.2 Diabeloop Business Overview
  70. 8.12.3 Diabeloop Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Diabeloop Bioartificial Organ Manufacturing Product Portfolio
  72. 8.12.5 Diabeloop Recent Developments
  73. 8.13 Admetsys
  74. 8.13.1 Admetsys Company Information
  75. 8.13.2 Admetsys Business Overview
  76. 8.13.3 Admetsys Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Admetsys Bioartificial Organ Manufacturing Product Portfolio
  78. 8.13.5 Admetsys Recent Developments
  79. 8.14 Defymed
  80. 8.14.1 Defymed Company Information
  81. 8.14.2 Defymed Business Overview
  82. 8.14.3 Defymed Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Defymed Bioartificial Organ Manufacturing Product Portfolio
  84. 8.14.5 Defymed Recent Developments
  85. 8.15 Pancreum
  86. 8.15.1 Pancreum Company Information
  87. 8.15.2 Pancreum Business Overview
  88. 8.15.3 Pancreum Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pancreum Bioartificial Organ Manufacturing Product Portfolio
  90. 8.15.5 Pancreum Recent Developments
  91. 8.16 Beta Bionics
  92. 8.16.1 Beta Bionics Company Information
  93. 8.16.2 Beta Bionics Business Overview
  94. 8.16.3 Beta Bionics Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beta Bionics Bioartificial Organ Manufacturing Product Portfolio
  96. 8.16.5 Beta Bionics Recent Developments
  97. 8.17 Integra LifeSciences
  98. 8.17.1 Integra LifeSciences Company Information
  99. 8.17.2 Integra LifeSciences Business Overview
  100. 8.17.3 Integra LifeSciences Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Integra LifeSciences Bioartificial Organ Manufacturing Product Portfolio
  102. 8.17.5 Integra LifeSciences Recent Developments
  103. 8.18 Wake Forest Institute for Regenerative Medicine (WFIRM)
  104. 8.18.1 Wake Forest Institute for Regenerative Medicine (WFIRM) Company Information
  105. 8.18.2 Wake Forest Institute for Regenerative Medicine (WFIRM) Business Overview
  106. 8.18.3 Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Product Portfolio
  108. 8.18.5 Wake Forest Institute for Regenerative Medicine (WFIRM) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst